GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » VGI Health Technology Ltd (XNEC:VTL) » Definitions » EBIT per Share

VGI Health Technology (XNEC:VTL) EBIT per Share : A$ (TTM As of . 20)


View and export this data going back to 2021. Start your Free Trial

What is VGI Health Technology EBIT per Share?

VGI Health Technology's EBIT per Share for the six months ended in . 20 was A$0.00. VGI Health Technology does not have enough years/quarters to calculate its EBIT per Share for the trailing twelve months (TTM) ended in . 20.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for VGI Health Technology's EBIT per Share or its related term are showing as below:

XNEC:VTL's 3-Year EBIT Growth Rate is not ranked *
in the Biotechnology industry.
Industry Median: 3.4
* Ranked among companies with meaningful 3-Year EBIT Growth Rate only.

VGI Health Technology's EBIT for the six months ended in . 20 was A$0.00 Mil.


VGI Health Technology EBIT per Share Historical Data

The historical data trend for VGI Health Technology's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

VGI Health Technology EBIT per Share Chart

VGI Health Technology Annual Data
Trend
EBIT per Share

VGI Health Technology Semi-Annual Data
EBIT per Share

VGI Health Technology EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

VGI Health Technology's EBIT per Share for the fiscal year that ended in . 20 is calculated as

EBIT per Share(A: . 20 )
=EBIT/Shares Outstanding (Diluted Average)
=/0
=N/A

VGI Health Technology's EBIT per Share for the quarter that ended in . 20 is calculated as

EBIT per Share(Q: . 20 )
=EBIT/Shares Outstanding (Diluted Average)
=/0
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


VGI Health Technology  (XNEC:VTL) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.


VGI Health Technology EBIT per Share Related Terms

Thank you for viewing the detailed overview of VGI Health Technology's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


VGI Health Technology (XNEC:VTL) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
19 Martin Place, Level 45, Suite 03, Sydney, NSW, AUS, 2003
VGI Health Technology Ltd develops and commercializes evidence-based nutraceuticals and pharmaceuticals. It has two evidence-based nutraceutical products ready for commercial launch in the US as well as a therapeutic drug development program. The nE1-Heart targets maintenance of heart health - tocotrienols have a similar mode of action (inhibition of HMCG CoA biosynthesis) as statins, the Gold Standard for treatment of hyperlipidaemia; and nE1-Eliteth that reduces Delayed Onset Muscle Soreness, improves muscle recovery after exercise, exercise endurance and maintenance of peak muscle power.

VGI Health Technology (XNEC:VTL) Headlines

No Headlines